Last Updated on February 23, 2023
Key Points
- Five additional vaccines have been approved by the Australian government for the purpose of international travel
Overview
On 17 Jan. 2022, the government of Australia approved five additional vaccines for the purpose of establishing a traveler’s vaccination status. Travelers will need to have received a two-dose vaccination regimen to be approved for travel to Australia. The following vaccines will be recognized for the purpose of travel:
- Comirnaty (Pfizer)
- Vaxzeviria (AstraZeneca)
- Spikevax or Takeda (Moderna)
- Janssen (Johnson & Johnson)
- Coronavac (Sinovac)
- Covishield (AstraZeneca – Serum Institute of India)
- BBIBP-CorV for people under the age of 60
- Covaxin (Bharat Biotech)
- Sputnik V (Gamaleya Research Institute)
What are the Changes?
The government of Australia has recognized more vaccine types for the purpose of travel. This change will allow more travelers to enter Australia with government approved vaccines.
Looking Ahead
Continue to check the government of Australia's website and Envoy’s website for additional updates and information.
Content in this publication is for informational purposes only and not intended as legal advice, nor should it be relied on as such. For additional information on the issues discussed, consult an attorney at one of the two U.S. Law Firms working with the Envoy Platform or another qualified professional. On non-U.S. immigration issues, consult an Envoy global immigration service provider or another qualified representative.
